The global personalized medicine market is anticipated to witness significant growth, with an expected value of USD 933.19 billion by the year 2030. According to recent market analysis, the market size for personalized medicine was estimated at USD 541.1 billion in 2022, indicating a steady upward trajectory with a Compound Annual Growth Rate (CAGR) of 7.05% during the forecast period from 2023 to 2030.

Personalized medicine, also known as precision medicine, leverages advancements in genomics, molecular diagnostics, and data analytics to tailor medical treatment and interventions to individual patient characteristics, including genetic makeup, biomarker profiles, and lifestyle factors. Key factors driving the growth of the personalized medicine market include:

Advancements in Genomic Sequencing and Molecular Diagnostics: Continuous advancements in genomic sequencing technologies, molecular diagnostics platforms, and bioinformatics tools are driving innovation in personalized medicine approaches, enabling the identification of disease-specific biomarkers and targeted therapies for individual patients.

Rise of Companion Diagnostics and Biomarker-based Therapies: The increasing adoption of companion diagnostics, biomarker-based therapies, and targeted cancer therapies is driving market growth and investment in personalized medicine strategies for oncology, autoimmune diseases, and rare genetic disorders, enabling precise treatment selection and monitoring.

Integration of Artificial Intelligence and Machine Learning: The integration of artificial intelligence (AI) and machine learning (ML) algorithms in personalized medicine analytics, predictive modeling, and clinical decision support systems is driving innovation in patient stratification, treatment optimization, and predictive risk assessment, enhancing clinical outcomes and healthcare efficiency.

Patient-centric Healthcare Models and Value-based Care: The shift towards patient-centric healthcare models, value-based care reimbursement models, and outcomes-based medicine is driving demand for personalized medicine approaches that prioritize patient engagement, shared decision-making, and individualized treatment plans, driving market growth and adoption.

Regulatory Support for Precision Medicine Initiatives: Supportive regulatory frameworks, expedited drug approvals, and regulatory incentives for precision medicine initiatives, including orphan drug designation, breakthrough therapy designation, and accelerated pathways, are driving investment in personalized medicine research, development, and commercialization.

Expansion of Pharmacogenomics and Therapeutic Drug Monitoring: The expansion of pharmacogenomics testing, therapeutic drug monitoring (TDM), and point-of-care diagnostics for drug metabolism and response prediction is driving demand for personalized medicine solutions in pharmacotherapy optimization, adverse drug reaction prevention, and medication safety initiatives.

KEY MARKET SEGMENTATION

By Product

  • Personalized Medicine Diagnostics
    • Genetic Testing
    • DTC Diagnostics
    • Others
  • Personalized Medicine Therapeutics
    • Pharmaceutical
    • Genomic Medicine
    • Medical Devices

By Application

  • Oncology
  • Neurology
  • Cardiology
  • Antiviral
  • Psychiatry
  • Immunology
  • Others

By End User

  • Hospitals and Clinical Care
  • Diagnostic Companies and Testing Facilities
  • Academic Research Institutes and Research Laboratories
  • Contract Research Organizations
  • Bio and Health Informatics Companies
  • Others

The major key players are GE Healthcare, Illumina, Inc., ASURAGEN, INC., Abbott, Dako A/S, Exact Sciences Corporation, Danaher Corporation (Cepheid, Inc.), Decode Genetics, Inc., QIAGEN, Exagen Inc., Precision Biologics, Celera Diagnostics LLC., Biogen, Genelex, Genentech, Inc., 23andMe, Inc., and Others.

As healthcare systems worldwide continue to embrace personalized medicine approaches, genomics-driven healthcare, and patient-centered care models, the personalized medicine market is expected to witness sustained growth, driven by technological innovation, clinical adoption, and increasing demand for precision medicine solutions that improve patient outcomes and healthcare value.

Other Reports You May Like:

Virtual Clinical Trials Market Size

Vitrectomy Devices Market Size

Functional Service Providers (FSP) Market Size

Geographic Atrophy (GA) Market Size

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com